What Are Stem Cells? Unlocking the Body’s Master Cells for Regenerative Medicine

Stem cells are making headlines, sparking hope for groundbreaking medical treatments. You might be wondering if these remarkable cells could offer a solution for you or someone you care about facing a serious illness. Let’s delve into the world of stem cells to understand what they are, their diverse types, their current and potential applications, and the exciting progress in research and clinical practice.

Stem Cells: The Body’s Master Cells

What exactly are stem cells? Think of them as the body’s fundamental building blocks, the origin from which all other specialized cells arise. From the blood coursing through your veins to the intricate network of nerve cells in your brain, and every cell in between, they all trace their lineage back to stem cells.

Stem cells are unique due to two remarkable properties. Firstly, they possess the ability to self-renew, meaning they can replicate themselves, creating more stem cells. Secondly, they can undergo differentiation, a fascinating process where they transform into specialized cells with distinct functions within the body. These master cells are not confined to a single location; they reside in virtually all tissues, acting as essential components for tissue maintenance and crucial for repair after injuries.

The fate of a stem cell, what type of specialized cell it becomes, is often determined by its location within the body. For instance, hematopoietic stem cells, nestled within the bone marrow, are responsible for producing all the diverse cells that circulate in our blood. Similarly, stem cells can differentiate into brain cells, the beating cells of the heart muscle, sturdy bone cells, and a vast array of other cell types, showcasing their incredible versatility.

Stem cells are not a monolithic group; they exist in various forms, each with its unique capabilities. Embryonic stem cells stand out as the most versatile, holding the potential to develop into any cell type found in a developing fetus. The majority of stem cells in our bodies, however, have a more restricted repertoire, primarily focused on maintaining and repairing the tissues and organs where they reside.

What sets stem cells apart is their unparalleled ability to generate new cell types, a capability no other cell in the body naturally possesses. This unique characteristic is the foundation of their immense scientific and therapeutic interest.

Why is There Such Intense Interest in Stem Cells?

Researchers are deeplyInvested in stem cell research, driven by their potential to revolutionize our understanding and treatment of diseases. Stem cells offer a unique window into:

• Understanding Disease Development: By observing stem cells as they mature into bone cells, heart muscle cells, nerve cells, and other tissue-specific cells, researchers gain invaluable insights into the intricate processes of human development. This, in turn, provides a clearer picture of how diseases and various health conditions arise at a cellular level.

• Regenerative Medicine: Repairing and Replacing Damaged Cells: Stem cells hold the promise of regenerative medicine. Scientists can guide stem cells to differentiate into specific cell types needed to repair or replace tissues damaged by disease or injury. This opens up therapeutic avenues for a wide range of conditions.

  Individuals suffering from leukemia, Hodgkin’s disease, non-Hodgkin lymphoma, and certain solid tumor cancers are among those who could potentially benefit from stem cell therapies. Furthermore, stem cell treatments are being explored for aplastic anemia, immunodeficiency disorders, and inherited metabolic conditions.

  The scope of stem cell research extends to prevalent and debilitating diseases such as type 1 diabetes, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), heart failure, osteoarthritis, and numerous other conditions, highlighting their broad therapeutic potential.

  Beyond treating diseases, stem cells offer the exciting prospect of growing new tissues in the laboratory. These lab-grown tissues could be used for transplants and regenerative medicine, providing a potential solution to organ donor shortages and revolutionizing how we treat tissue damage. Researchers are continually expanding our knowledge of stem cells and their applications in these groundbreaking areas.

• Drug Development and Safety Testing: Stem cells are becoming increasingly important in pharmaceutical research. Before new drugs are tested in humans, certain types of stem cells can be used to assess their safety and effectiveness. This preclinical testing phase is crucial for identifying potential toxicity or adverse effects early in the drug development process. For instance, stem cells can be used to evaluate the potential cardiotoxicity (heart damage) of new drugs.

  Emerging research focuses on utilizing human stem cells, reprogrammed into tissue-specific cells, to create more accurate drug testing models. For drug testing to be reliable, the stem cells must accurately mimic the properties of the cells targeted by the drug. Scientists are actively developing and refining techniques to precisely program stem cells into these specific cell types, enhancing the accuracy and predictive power of drug testing.

Where Do Stem Cells Come From?

The remarkable potential of stem cells is harnessed from several sources, each with unique characteristics and applications:

• Embryonic Stem Cells: These pluripotent stem cells are derived from embryos at a very early stage of development, typically 3 to 5 days old. At this stage, the embryo, known as a blastocyst, is a cluster of approximately 150 cells.

  Embryonic stem cells are classified as pluripotent, signifying their extraordinary ability to differentiate into any cell type in the body, as well as to self-renew indefinitely. This pluripotency makes them incredibly valuable for regenerative medicine, offering the potential to repair or replace a wide spectrum of diseased tissues and organs.

• Adult Stem Cells: Also known as somatic stem cells, adult stem cells are found in small numbers within most adult tissues, including bone marrow and fat tissue. In contrast to embryonic stem cells, adult stem cells exhibit a more restricted differentiation capacity. They are multipotent, meaning they can differentiate into a limited number of cell types, typically those related to their tissue of origin. Their primary role is in tissue maintenance and repair within their resident tissue.

• Induced Pluripotent Stem Cells (iPSCs): A groundbreaking advancement in stem cell research is the ability to reprogram adult cells to behave like embryonic stem cells. Scientists achieve this cellular transformation through genetic reprogramming, altering the genes within adult cells. These reprogrammed cells are called induced pluripotent stem cells (iPSCs).

  iPSCs offer several significant advantages. They circumvent the ethical concerns associated with using embryonic stem cells and can potentially overcome the issue of immune rejection. Since iPSCs can be generated from a patient’s own cells, they are genetically matched, reducing the risk of the recipient’s immune system attacking the transplanted cells. However, research is ongoing to fully understand the long-term safety of iPSCs and to ensure that using altered adult cells does not lead to any unforeseen adverse effects in humans.

  Remarkable progress has been made in reprogramming various adult cell types. For example, researchers have successfully reprogrammed regular connective tissue cells into functional heart cells. Animal studies have shown promising results, with animals suffering from heart failure exhibiting improved heart function and increased survival time after being injected with these new, lab-grown heart cells.

• Perinatal Stem Cells: Emerging research has identified stem cells in amniotic fluid and umbilical cord blood, both readily available sources typically discarded after birth. These perinatal stem cells possess the ability to differentiate into specialized cells, making them another promising avenue for research and potential therapeutic applications.

  Amniotic fluid, the protective liquid surrounding a developing fetus in the uterus, is a source of these stem cells. Amniocentesis, a procedure performed during pregnancy for prenatal testing or treatment, provides access to amniotic fluid samples, which can be used to harvest perinatal stem cells.

Why is There Controversy About Using Embryonic Stem Cells?

The use of embryonic stem cells in research and therapy has sparked ethical debate, primarily because they are derived from early-stage embryos. These embryos are typically obtained from in vitro fertilization (IVF) clinics, representing the earliest stage of human development. This raises complex ethical questions about the moral status of embryos and the appropriateness of using them for research purposes.

Recognizing these ethical considerations, the National Institutes of Health (NIH) established guidelines in 2009 to govern human stem cell research. These guidelines provide a framework for the ethical and responsible use of embryonic stem cells in research. They define embryonic stem cells, outline permissible research uses, and include recommendations for the donation of embryonic stem cells. Crucially, the NIH guidelines stipulate that embryonic stem cells derived from IVF embryos can only be used for research when the embryos are no longer needed for reproductive purposes.

Where Do These Embryos Come From?

The embryos used in embryonic stem cell research are sourced from eggs fertilized at in vitro fertilization (IVF) clinics that were not subsequently implanted in a woman’s uterus. These are often referred to as “excess” embryos, created during IVF procedures but no longer needed for fertility treatment. The donation of these embryos for stem cell research is conducted with informed consent from the donors, the individuals or couples who underwent IVF. Once donated, these stem cells can be cultured and grown in specialized solutions within laboratories, forming stem cell lines for ongoing research and experimentation.

Why Can’t Researchers Use Adult Stem Cells Instead?

Significant progress in cell reprogramming and the development of iPSCs has indeed revolutionized the stem cell field and provided a valuable alternative. iPSCs have become a preferred option in many research areas, particularly when ethical concerns surrounding embryonic stem cell use are a major consideration. However, it’s important to acknowledge that reprogramming adult cells into iPSCs is still an inefficient process, and research is ongoing to improve its efficiency and reliability.

While adult stem cell research is undeniably promising and has yielded important advancements, adult stem cells may not possess the same level of versatility and long-term durability as embryonic stem cells. Adult stem cells typically have a more limited differentiation potential, meaning they may not be able to be manipulated to produce the full spectrum of cell types that embryonic stem cells can. This limitation can restrict their application in treating certain complex diseases requiring a wide range of cell types for regeneration or repair.

Furthermore, adult stem cells, having resided in a mature organism throughout its lifespan, are more susceptible to accumulating irregularities. These irregularities can arise from exposure to environmental hazards like toxins or from errors that occur naturally during cell replication over time. These accumulated irregularities can potentially affect the functionality and therapeutic potential of adult stem cells.

Despite these limitations, it’s crucial to recognize that research into adult stem cells has also revealed remarkable adaptability. Scientists are continually discovering that adult stem cells are more flexible and capable than initially thought, expanding their potential applications in regenerative medicine.

What are Stem Cell Lines, and Why Do Researchers Want to Use Them?

A stem cell line is essentially a population of cells that originate from a single, original stem cell and are cultivated and expanded in a laboratory setting. The cells within a stem cell line are descendants of this initial stem cell, continuously dividing and proliferating in culture. Ideally, stem cell lines are maintained in a state where they continue to grow and self-renew but do not spontaneously differentiate into specialized cells. Researchers strive to ensure that these cell lines remain free from genetic defects and retain their capacity to generate more stem cells indefinitely.

Stem cell lines are incredibly valuable research tools. Clusters of cells can be extracted from a stem cell line, frozen for long-term storage (cryopreservation), or readily shared with other researchers across the globe. This sharing and distribution of stem cell lines accelerate research progress, allowing multiple labs to work with standardized and well-characterized stem cell populations, fostering collaboration and reproducibility in stem cell research.

What is Stem Cell Therapy (Regenerative Medicine), and How Does it Work?

Stem cell therapy, often referred to as regenerative medicine, represents a paradigm shift in treating diseases and injuries. It leverages the remarkable repair capabilities of stem cells to promote the regeneration of diseased, dysfunctional, or injured tissues. Rather than relying solely on traditional organ transplantation, which is limited by donor organ availability, stem cell therapy aims to use cells themselves as therapeutic agents. It is considered the next frontier in organ transplantation, offering the potential to overcome organ shortages and revolutionize the treatment of a wide range of conditions.

The process of stem cell therapy typically involves growing stem cells in a specialized laboratory environment. Scientists then carefully manipulate these stem cells, providing specific signals and cues to guide them to differentiate into particular cell types, such as heart muscle cells, blood cells, or nerve cells, depending on the therapeutic need.

Once the stem cells have differentiated into the desired specialized cell type, they can be implanted into a patient. For example, in a patient with heart disease, lab-grown heart muscle cells could be directly injected into the damaged heart tissue. The expectation is that these healthy, transplanted heart muscle cells will integrate with the existing heart tissue and contribute to repairing the injured heart muscle, restoring function and improving cardiac health.

Groundbreaking research has already demonstrated the feasibility of this approach. Studies have shown that adult bone marrow cells, when guided to differentiate into heart-like cells in the lab, can effectively repair damaged heart tissue in humans. This pioneering work has paved the way for ongoing and expanding research in stem cell therapy for heart disease and other conditions.

Have Stem Cells Already Been Used to Treat Diseases?

Yes, stem cell transplantation is not a futuristic concept; it’s a reality. Doctors have been performing stem cell transplants, frequently known as bone marrow transplants, for several decades. These procedures are well-established treatments for specific medical conditions. In hematopoietic stem cell transplants, the primary goal is to replace blood-forming stem cells that have been damaged or destroyed by high-dose chemotherapy or diseases affecting the bone marrow. In some cases, stem cell transplants are also used as a way to harness the donor’s immune system to target and fight certain types of cancer and blood-related diseases.

Hematopoietic stem cell transplantation is a standard treatment for various cancers, including leukemia, lymphoma (both Hodgkin’s and non-Hodgkin’s lymphoma), neuroblastoma, and multiple myeloma. These transplants utilize adult stem cells, often harvested from bone marrow, peripheral blood, or umbilical cord blood, depending on the specific clinical situation and patient needs.

Beyond these established applications, researchers are actively exploring the therapeutic potential of adult stem cells for a broader spectrum of conditions. This includes investigating their use in treating degenerative diseases, such as heart failure, where stem cells could potentially regenerate damaged heart tissue and improve cardiac function. Clinical trials are underway to evaluate the safety and efficacy of stem cell therapies for various degenerative conditions, holding promise for future medical advancements.

What are the Potential Problems with Using Embryonic Stem Cells in Humans?

While embryonic stem cells hold immense promise, their therapeutic application in humans is not without potential challenges. Researchers must address several key issues to ensure the safe and effective use of embryonic stem cells in treatments:

• Directed Differentiation: A critical challenge is ensuring that embryonic stem cells differentiate precisely into the desired specific cell types needed for therapy. Uncontrolled differentiation could lead to the formation of unwanted cell types, potentially causing complications.

  Significant progress has been made in directing stem cell differentiation. Researchers have developed sophisticated methods to guide embryonic stem cells to become specific cell types, such as heart cells, nerve cells, or insulin-producing pancreatic cells. However, this is an ongoing area of intensive research, aiming for even greater precision and efficiency in directing stem cell fate.

• Tumor Formation and Irregular Growth: Embryonic stem cells have the inherent capacity to proliferate rapidly and differentiate into various cell types. However, this potential also carries a risk. Embryonic stem cells can sometimes grow uncontrollably or spontaneously differentiate into a mixture of different cell types in an unregulated manner. This uncontrolled growth raises concerns about the potential for tumor formation or the development of unwanted tissues at the transplantation site. Researchers are actively studying how to tightly control the growth and differentiation of embryonic stem cells to mitigate these risks.

• Immune Rejection: A significant immunological challenge is the potential for immune rejection. Embryonic stem cells, derived from embryos, are genetically distinct from the recipient’s body. Therefore, the recipient’s immune system may recognize the transplanted embryonic stem cells as foreign invaders and mount an immune response, attacking and rejecting the cells. This immune rejection can negate the therapeutic benefits of the stem cell transplant. Researchers are exploring various strategies to minimize or prevent immune rejection, including immunosuppression and developing methods to create immunologically compatible stem cells.

• Functional Failure and Unknown Consequences: Even if embryonic stem cells are successfully transplanted and integrate into the recipient’s tissues, there is a possibility that they may not function as expected or may have unforeseen long-term consequences. The complex interactions of stem cells within the body are still not fully understood. Researchers are conducting thorough investigations to assess the long-term functionality, safety, and potential risks associated with embryonic stem cell therapies, ensuring responsible and ethical clinical translation.

What is Therapeutic Cloning, and What Benefits Might it Offer?

Therapeutic cloning, also known as somatic cell nuclear transfer (SCNT), is a sophisticated technique aimed at creating versatile stem cells without the use of fertilized eggs. This approach offers a potential solution to some of the ethical and immunological challenges associated with embryonic stem cells.

In therapeutic cloning, the nucleus, which contains the genetic material, is carefully removed from an unfertilized egg cell. Simultaneously, a nucleus is extracted from a somatic cell (any non-reproductive cell) of a donor individual.

This donor nucleus is then meticulously injected into the enucleated egg, replacing the original egg nucleus. This process, known as nuclear transfer, essentially reprograms the egg cell using the genetic material from the donor cell. The reconstructed egg is then stimulated to divide and develop, eventually forming a blastocyst, the early-stage embryo from which embryonic stem cells are derived.

The stem cells derived through therapeutic cloning are genetically identical to the donor’s cells, essentially creating a clone at the cellular level. This genetic matching offers significant potential advantages in therapeutic applications.

Researchers believe that stem cells generated through therapeutic cloning may offer several benefits compared to those derived from fertilized eggs:

• Reduced Risk of Immune Rejection: Since the cloned stem cells are genetically identical to the donor’s cells, they are less likely to trigger an immune response and be rejected by the recipient’s body after transplantation. This reduces or eliminates the need for immunosuppressive drugs, which have their own side effects.

• Disease Modeling and Research: Therapeutic cloning provides a powerful tool for studying disease development. By creating stem cell lines genetically matched to patients with specific diseases, researchers can investigate the cellular and molecular mechanisms underlying these conditions. This can facilitate the development of targeted therapies and personalized medicine approaches.

Has Therapeutic Cloning in People Been Successful?

Despite successful therapeutic cloning in various animal species, researchers have not yet achieved consistent success in performing therapeutic cloning in humans. While significant progress has been made in understanding the underlying cellular and molecular processes, replicating the success seen in animals in human cells has proven to be a complex scientific hurdle.

Researchers worldwide continue to actively investigate and refine therapeutic cloning techniques for human cells. Overcoming the technical challenges associated with human therapeutic cloning remains a priority in stem cell research, as its successful implementation could unlock significant advancements in regenerative medicine and disease treatment.

From Mayo Clinic to your inbox

Stay informed about the latest research breakthroughs, health tips, and expert insights by subscribing to our free email newsletter. Click here for an email preview.

ErrorEmail field is required

ErrorInclude a valid email address

To provide you with the most relevant information and understand what’s helpful, we may combine your email and website data with other information we have about you. If you’re a Mayo Clinic patient, this might include protected health information. If we combine this with your health information, we will treat it all as protected health information and only use or share it as described in our privacy practices. You can unsubscribe from emails anytime by clicking the link in the email.

Thank you for subscribing!

You’ll soon receive the latest Mayo Clinic health updates in your inbox.

Sorry something went wrong with your subscription

Please try again in a few minutes.

March 23, 2024

References

1. Stem cell basics. National Institutes of Health. https://stemcells.nih.gov/info/basics/stc-basics/#stc-I. Accessed March 21, 2024.
2. Lovell-Badge R, et al. ISSCR guidelines for stem cell research and clinical translation: The 2021 update. Stem Cell Reports. 2021; doi:10.1016/j.stemcr.2021.05.012.
3. AskMayoExpert. Hematopoietic stem cell transplant. Mayo Clinic; 2024.
4. Stem cell transplants in cancer treatment. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/. Accessed March 21, 2024.
5. Townsend CM Jr, et al. Regenerative medicine. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 21, 2024.
6. Kumar D, et al. Stem cell based preclinical drug development and toxicity prediction. Current Pharmaceutical Design. 2021; doi:10.2174/1381612826666201019104712.
7. NIH guidelines for human stem cell research. National Institutes of Health. https://stemcells.nih.gov/research-policy/guidelines-for-human-stem-cell-research. Accessed March 21, 2024.
8. De la Torre P, et al. Current status and future prospects of perinatal stem cells. Genes. 2020; doi:10.3390/genes12010006.
9. Yen Ling Wang A. Human induced pluripotent stem cell-derived exosomes as a new therapeutic strategy for various diseases. International Journal of Molecular Sciences. 2021; doi:10.3390/ijms22041769.
10. Alessandrini M, et al. Stem cell therapy for neurological disorders. South African Medical Journal. 2019; doi:10.7196/SAMJ.2019.v109i8b.14009.
11. Goldenberg D, et al. Regenerative engineering: Current applications and future perspectives. Frontiers in Surgery. 2021; doi:10.3389/fsurg.2021.731031.
12. Brown MA, et al. Update on stem cell technologies in congenital heart disease. Journal of Cardiac Surgery. 2020; doi:10.1111/jocs.14312.
13. Li M, et al. Brachyury engineers cardiac repair competent stem cells. Stem Cells Translational Medicine. 2021; doi:10.1002/sctm.20-0193.
14. Augustine R, et al. Stem cell-based approaches in cardiac tissue engineering: Controlling the microenvironment for autologous cells. Biomedical Pharmacotherapy. 2021; doi:10.1016/j.biopha.2021.111425.
15. Cloning fact sheet. National Human Genome Research Institute. https://www.genome.gov/about-genomics/fact-sheets/Cloning-Fact-Sheet. Accessed March 21, 2024.
16. Dingli D (expert opinion). Mayo Clinic. Nov. 17, 2023.